During the past decade, LLL Medical Center Revma-Med conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LLL Medical Center Revma-Med" are "Arthritis, Psoriatic" (3 trials), "Lupus Nephritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Active Psoriatic Arthritis" (1 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "LLL Medical Center Revma-Med" in a lesser frequency.

Most popular intervention types in "LLL Medical Center Revma-Med" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (3 trials), "Standard-of-care treatment" (2 trials), "BMS-986165 Dose A" (1 trials) and "BMS-986165 Dose B" (1 trials). Other intervention names were less common.

The vast majority of trials in "LLL Medical Center Revma-Med" are 9 trials for "All" genders.

Currently, there are NaN active trials in "LLL Medical Center Revma-Med". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in LLL Medical Center Revma-Med, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LLL Medical Center Revma-Med, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".